acetylcysteine (Rx)
(a-se-teel-sis'tay-een)
Func. class.: Mucolytic; antidote-acetaminophen
Chem. class.: Amino acid l-cysteine
Do not confuse:
acetylcysteine/acetylcholine
Decreases viscosity of secretions by breaking disulfide links of mucoproteins; serves as a substrate in place of glutathione, which is necessary to inactivate toxic metabolites with acetaminophen overdose
Acetaminophen toxicity; bronchitis; cystic fibrosis; COPD; atelectasis
Precautions: Pregnancy, breastfeeding, hypothyroidism, Addison's disease, CNS depression, brain tumor, asthma, renal/hepatic disease, COPD, psychosis, alcoholism, seizure disorders, bronchospasms, anaphylactoid reactions, fluid restriction, weight <40 kg, increased intracranial pressure, status asthmaticus
Acetaminophen toxicity
Adult and child:≥41-100 kg IV loading dose 150 mg/kg over 60 min (dilution 150 mg/kg in 200 mL of D5W); then 50 mg/kg over 4 hr (dilution 50 mg/kg in 500 mL D5W); then 100 mg/kg over 16 hr (dilution 100 mg/kg in 1000 mL D5W)
Adult/child 21-40 kg: IV 150 mg/kg in 100 mL diluent over 1 hr, then 50 mg/kg in 250 mL over 4 hr, then 100 mg/kg in 500 mL over 16 hr
Infant/child 5-20 kg: IV 150 mg/kg in 3 mL/kg diluent over 1 hr, then 50 mg/kg in 7 mL/kg diluent over 4 hr, then 100 mg/kg in 14 mL/kg diluent over 16 hr
Bronchopulmonary disease (mucolytic)
Give bronchodialators 15 min before acetylsteine
Adult and child 1-12 yr: INSTILL 1-2 mL (10%-20% solution) q2-6hr prn or 3-5 mL (20°% solution) or 6-10 mL (10°% sol) tid or qid; NEBULIZER (face mask, mouthpiece, tracheostomy) 1-10 mL of a 20% sol, or 2-20 mL of a 10% sol, q2-8hr; NEBULIZER (tent, croupette) may require large dose, up to 300 mL/treatment
Tracheostomy care
Adult/child: INSTILL 1-2 mL (10%-20% sol) q1-4hr directly into tracheostomy
Diagnostic bronchial lab studies
Adult/child: NEBULIZER 2-3 uses of 1-2 mL of 20% sol or 2-4 mL of 10% sol
Available forms:Inhalation solution 10%, 20%; inj 20% (200 mg/mL)
Administer:
Direct intratracheal instill route
By syringe: 1-2 mL of 10%-20% solution up to q1hr
Decreased dose to geriatric patients; metabolism may be slowed
Only if suction machine is available
Only after patient clears airway by deep breathing, coughing
Assistance with inhaled dose: bronchodilator if bronchospasm occurs; mechanical suction if cough insufficient to remove excess bronchial secretions
IV route
21-hr regimen: loading dose: dilute 150 mg/kg in 200 mL D5W; maintenance dose 1: dilute 50 mg/kg in 500 mL D5W; maintenance dose 2: dilute 100 mg/kg in 1000 mL D5W; give loading dose over 15 min; give maintenance dose 1 over 4 hr; give maintenance dose 2 over 16 hr, administer sequentially without time between doses
Store in refrigerator; use within 96 hr of opening
CNS:Dizziness, drowsiness,fever, chills
CV:Edema, flushing tachycardia
EENT:Rhinorrhea,pharyngitis
GI:Nausea, stomatitis, vomiting, anorexia
INTEG:Urticaria, rash, clamminess, pruritus
RESP: Bronchospasm, chest tightness, cough, dyspnea
MISC:Anaphylaxis, angioedema, unpleasant odor
Side effects: italics = common; red = life-threatening
IV: Excreted in urine, half-life 5.6 hr (adult), 11 hr (newborn), protein binding 83%, peak 5-10 min (INH)
Assess:
Mucolytic use: cough-type, frequency, character, including sputum; bronchospasm
Rate, rhythm of respirations, increased dyspnea; sputum
VS, cardiac status including checking for dysrhythmias, increased rate, palpitations
Labs: ABGs for increased CO2 retention in asthma patients
Antidotal use: use within 24 hr of acetaminophen toxicity, give within 10 hr of acetaminophen to minimize hepatotoxicity; monitor LFTs, PT, BUN, creatinine, glucose, electrolytes, acetaminophen levels; inform prescriber if dose is vomited or if vomiting is persistent; 150 mg/kg may be toxic, check acetaminophen level q4hr
Bronchospasm: discontinue, notify health care provider if bronchospasm occurs
Hypersensitivity: anaphylaxis may occur with IV dose; if present, stop infusion, treat, restart; assess for dyspnea, swelling of face, lips, tongue; rash, itching
Nausea, vomiting, rash; notify prescriber if these occur
Pregnancy/breastfeeding: use only if clearly needed; cautious use in breastfeeding, excretion unknown
Evaluate:
Therapeutic response: absence of purulent secretions when coughing, clear lung sounds (mucolytic use); absence of hepatic damage with acetaminophen toxicity
Teach patient/family:
That foul odor and smell may be unpleasant
To clear airway for inhalation
To report vomiting because dose may need to be repeated
Provide adequate hydration
Teach coughing and deep breathing
Acetaminophen toxicity: Explain reason for product, expected result